Kaiser has distributed more than 10 million colorectal cancer screening kits since the program's inception
MIRA LOMA, Calif., March 5, 2019 (Newswire.com) - In honor of National Colorectal Cancer Awareness Month, Bridgecom® hosts a complimentary webinar titled “Colorectal Cancer: It’s Time to Make a Difference” on how to launch or optimize a colorectal cancer screening program at healthcare organizations to improve outreach compliance and patient outcomes.
Gail Lindsay, R.N., M.A., explains how to implement a formal colorectal cancer disease screening and detection outreach program at former employer Kaiser Permanente Southern California. In her previous role, Lindsay was the co-architect of the Complete Care Program, which employed a centralized approach to holistic care delivery that integrates analytics, care gap prioritization, population health and outreach practices and reporting across diverse disease states, including cancer. Kaiser has performed more than 10 million colorectal cancer screenings since the program’s inception. Currently, Lindsay is chief quality officer for the Southern California Region at Providence St. Joseph Health.
Attendees will learn the best colorectal cancer screening methods and recommendations for cohesive screening-specific activities proven to drive patient compliance. Lindsay’s programmatic outreach approach also can be applied at organizations to improve outcomes and better manage total costs of care. Healthcare leaders, clinical quality directors, clinicians and other professionals at hospitals and integrated delivery networks, payers and self-insured, large-group employers are invited to the webcast.
WHY: President Clinton declared March as National Colorectal Cancer Awareness Month in February 2000. According to the Colorectal Cancer Alliance, colorectal cancer is the third most commonly diagnosed cancer in the U.S. and is the second leading cause of cancer deaths with women and men combined. An estimated 51,020 deaths from colorectal cancer will occur in 2019.
U.S. Preventive Services Task Force recommends colorectal cancer screening should begin at age 50. An Annals of Internal Medicine study reported Feb. 26 that a single application fecal immunochemical test (FIT) screening can have up to 90 percent sensitivity for colorectal cancer.
Bridgecom is a software and services company that provides healthcare organizations a powerful way to close communication and care gaps. The company’s unique blend of technology and patented processes improve patient outcomes and dramatically reduce costs. Bridgecom’s immunochemical fecal occult blood test (iFOBT)/FIT at-home test kit works in concert with an integrated platform to help organizations standardize the colorectal cancer screening outreach process. The platform effectively engages patient or member recipients through personalized notifications designed to educate and move them to action achieving compliance. Visit bridgecomsolutions.com.
Angela Jenkins & Associates
Brad Hibbard, Vice President, Sales & Marketing